LBH589 10mg 10mg | Purity Not Available
Adooq Bioscience
LBH589 is a hydroxamic acid and acts as a non-selective HDAC inhibitor with IC5o of HDAC1 to be 0.23 nM.
More Information Supplier PageLBH589 is a hydroxamic acid and acts as a non-selective HDAC inhibitor with IC5o of HDAC1 to be 0.23 nM.
More Information Supplier PageL-Ascorbyl 6-palmitate (Ascorbyl palmitate) is an ester formed from ascorbic acid and palmitic acid creating a fat-soluble form of vitamin C.
More Information Supplier PageL-Ascorbyl 6-palmitate (Ascorbyl palmitate) is an ester formed from ascorbic acid and palmitic acid creating a fat-soluble form of vitamin C.
More Information Supplier PageL-Ascorbyl 6-palmitate (Ascorbyl palmitate) is an ester formed from ascorbic acid and palmitic acid creating a fat-soluble form of vitamin C.
More Information Supplier PageL-Ascorbyl 6-palmitate (Ascorbyl palmitate) is an ester formed from ascorbic acid and palmitic acid creating a fat-soluble form of vitamin C.
More Information Supplier PageLAQ824 (NVP-LAQ824) is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma.
More Information Supplier PageLAQ824 (NVP-LAQ824) is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma.
More Information Supplier PageLAQ824 (NVP-LAQ824) is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma.
More Information Supplier PageLBH589 is a hydroxamic acid and acts as a non-selective HDAC inhibitor with IC5o of HDAC1 to be 0.23 nM.
More Information Supplier PageLBH589 is a hydroxamic acid and acts as a non-selective HDAC inhibitor with IC5o of HDAC1 to be 0.23 nM.
More Information Supplier Page